Treatment of alcoholic hepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 448-455

  Maher, Jacquelyn J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Alcoholic hepatitis; Anti oxidant therapy; Corticosteroids; Liver transplantation; Medium chain triglycerides; Mortality; Nutritional therapy; Pentoxifylline; Propylthiouracil; S adenosyl methionine; Silymarin; Treatment

Indexed keywords

AMLODIPINE; ANTIFIBROTIC AGENT; ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPHENYLIODONIUM SALT; EBSELEN; GLYCINE; MEDIUM CHAIN TRIACYLGLYCEROL; METHYLPREDNISOLONE; NIMODIPINE; PENTOXIFYLLINE; PREDNISOLONE; PROPYLTHIOURACIL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; S ADENOSYLMETHIONINE; TUMOR NECROSIS FACTOR;

ALCOHOL LIVER DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; HIGH RISK POPULATION; HUMAN; HYPERMETABOLISM; INFECTION RISK; INFLAMMATION; KUPFFER CELL; LIVER TRANSPLANTATION; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SURVIVAL;

EID: 0036097132     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02722.x     Document Type: Conference Paper

References (47)

1. VA Cooperative Study on Alcoholic Hepatitis. IV. The significance of clinically mild alcoholic hepatitis - Describing the population with minimal hyperbilirubinemia
2. Corticosteroid therapy of alcoholic hepatitis
3. Methyl-prednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial
4. A randomized trial of prednisolone in patients with severe alcoholic hepatitis
5. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone
6. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
7. A model to predict survival in patients with end-stage liver disease
8. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis
9. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo
10. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor
11. Mechanisms of alcohol-induced hepatotoxicity: Studies in rats
12. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease
13. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease
14. Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis
15. Long-term treatment of alcoholic liver disease with propylthiouracil
16. Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis
17. Effect of antithyroid drugs on hydroxyl radical formation and alpha-1-proteinase inhibitor inactivation by neutrophils: Therapeutic implications
18. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials
19. Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology
20. Glucocorticoids are ineffective in alcoholic hepatitis: A meta-analysis adjusting for confounding variables
21. Short-and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial
22. Drugs that alter blood viscosity. Their role in therapy
23. Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis
24. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease
25. Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol
26. Activation of voltage-dependent calcium channels in Kupffer cells by chronic treatment with alcohol in the rat
27. Nimodipine, a dihydropyridine-type calcium channel blocker, prevents alcoholic hepatitis caused by chronic intragastric ethanol exposure in the rat
28. Glycine accelerates recovery from alcohol-induced liver injury
29. Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis
30. Ebselen prevents early alcohol-induced liver injury in rats
31. Diphenyleneiodo-nium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat
32. S-adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial
33. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver
34. Effects of silymarin in alcoholic patients with cirrhosis of the liver: Results of a controlled, double-blind, randomized and multicenter trial
35. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification
36. Effects of long-term vitamin E supplementation in alcoholic cirrhotics
37. Attenuation of alcohol-induced apoptosis of hepatocytes in rat livers by poly-enylphosphatidylcholine
38. Poly-enylphosphatidylcholine opposes the increase of cytochrome P-4502E1 by ethanol and corrects its iron-induced decrease
39. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon
40. Polyenylphosphatidylcholine inhibits PDGF-induced proliferation in rat hepatic stellate cells
41. Colchicine in the treatment of cirrhosis of the liver
42. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial
43. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis
44. Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis
45. Rapidly progressive liver injury and fatal alcoholic hepatitis occurring after liver transplantation in alcoholic patients
46. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus
47. Quality of life after liver transplantation for alcoholic liver disease